Paratek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China Region
BOSTON, Feb. 24, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]